P01.060 PriCoTTF: a phase I/II trial of Tumor Treating Fields prior and concomitant to radiotherapy in newly diagnosed glioblastoma

OBJECTIVE: Tumor Treating Fields (TTFields) in combination with adjuvant temozolomide (TMZ) as therapy for newly diagnosed glioblastoma (GBM) patients showed significantly increased progression-free survival (PFS), overall survival (OS) and long-term survival rates in the EF-14 phase III trial. In t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Glas, M, Scheffler, B, Lazaridis, L, Herrlinger, U, Pierscianek, D, Sure, U, Pröscholdt, M, Hau, P, Hense, J, Kleinschnitz, C, Grosu, A, Stuschke, M, Kebir, S
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144449/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.102
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars